Skip to main content
Explore URMC

Robert M. Kottmann, M.D.

Contact Information

Phone Numbers

Office: (585) 275-4161

Fax: (585) 273-1171

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting




  • Critical Care Medicine
  • Internal Medicine - American Board of Internal Medicine
  • Pulmonary Disease - American Board of Internal Medicine

Post-doctoral Training & Residency

07/01/2004 - 06/30/2007
Fellowship in Pulmonary Diseases & Critical Care at University of Rochester Medical Center

06/24/2002 - 06/23/2004
Residency in Internal Medicine at University of Rochester Medical Center

06/24/2001 - 06/23/2002
Internship in Internal Medicine at University of Rochester Medical Center

VIEW ALL expand_more


Patent Title: LDH Inhibitors as Treatment for Fibrosis and for Fibrotic-Related Disorders
Patent #: 9,750,761
Issue Date: Sep 05, 2017
Country: United States
Invented By: Robert Matthew Kottmann, Richard P Phipps, Patricia Janet Sime


Journal Articles

Wu EK, Ambrosini RD, Kottmann RM, Ritchlin CT, Schwarz EM, Rahimi H. "Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology." Current rheumatology reviews.. 2019 Jan 15; Epub 2019 Jan 15.

Lachant DJ, Croft DP, McGrane Minton H, Hardy DJ, Prasad P, Kottmann RM. "The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients." Respiratory medicine.. 2018 Dec 0; 145:35-40. Epub 2018 Oct 22.

Judge JL, Nagel DJ, Owens KM, Rackow A, Phipps RP, Sime PJ, Kottmann RM. "Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol." PloS one.. 2018 13(5):e0197936. Epub 2018 May 24.